Eli Lilly and Company · Q1 2025
ReportedMay 1, 2025
Period endedMar 31, 2025
Rule of 40+46
The quarter in short
Revenue $12.73B, up 45.2% year over year and down 5.9% on the quarter. EPS $3.06, up 23.4% year over year and down 37.3% on the quarter. Free cash flow $156M, down 13.2% year over year and 84.0% on the quarter. Rule of 40 score +46.
Reported this quarter
Revenue
$12.73B
QoQ −5.9%
YoY +45.2%
EPS
$3.06
QoQ −37.3%
YoY +23.4%
Free Cash Flow
$156M
QoQ −84.0%
YoY −13.2%
Gross Margin
82.5%
QoQ +0.3 pp
YoY +1.6 pp
FCF Margin
1.2%
QoQ −6.0 pp
YoY −0.8 pp
P/E Ratio
66.8
QoQ +1.7%
YoY −41.5%
Each tile opens the full quarterly series. Download the numbers as CSV or JSON.
Sources & downloads
Company
Published by the company on the day of the release.
HTML
Earnings press release
Investor relations announcement
SEC filings
Filed with the SEC under CIK 59478.
HTML
8-K results announcement
Filed May 1, 2025
HTM
Press release (EX-99.1)
Exhibit 99.1 to the 8-K
166 KB
HTML
Filing index
Every document in the 8-K submission
TXT
Complete submission
Raw archival text of the whole filing
HTML
10-Q quarterly report
Period ended Mar 31, 2025, filed May 1, 2025
ZIP
XBRL data bundle
Structured financial statements from the 10-Q
JSON
Company facts (XBRL)
Every figure LLY has reported to the SEC
R40 data
The numbers shown on this page, as we hold them.
CSV
This quarter (CSV)
Reported metrics for Q1 2025, spreadsheet-ready
JSON
This quarter (JSON)
Metrics, dates and matched filings